Abstract
1559 Background: Our research goal was to provide timely estimates of economic burden of brain cancer to the US healthcare system for patients (pts) across the US, and identify primary cost drivers. Methods: Retrospective cohort analysis of direct costs and healthcare services use in brain cancer pts and controls was conducted using MarketScan™ US employers' claims databases of over 3 million individuals. Cases were pts newly diagnosed with brain cancer in 1999–2000. Controls were individuals without cancer diagnosis and matched 3:1 with cases (97.5% match) on age, gender, healthcare coverage, region (e.g., West), and follow-up length. Utilization of healthcare services and costs were standardized to monthly means. Results: The study consisted of 652 cases and 1,959 controls. 40% of cases had late stage disease. Median age was 56 years for cases and 55 years for controls. Mean follow-up was 10.9 months for both groups. Mean monthly rates of hospitalizations, length of stay, emergency room visits, office v...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
